SMTI

Sanara MedTech Inc.

32.24 USD

Last updated Nov 30, 08:30 UTC

Yesterday HIGH

$33.31

Yesterday LOW

$31.9

52w HIGH

$50.18

52w LOW

$26.06

EPS

-0.13

PE

-248.00

Next Earnings

Mar 18, 2024

Overview News Government Trades

Sanara MedTech Inc. stock is up 17.28% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 24.14% of the previous 32 November’s closed higher than October. 100% of analysts rate it a buy.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel for the management of full and partial thickness wounds.

Stock Exchange

OTC

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Website

sanaramedtech.com

Benzinga Newsdesk

Mon May 15, 2023

Sanara MedTech Q1 Sales $15.50M Miss $16.20M Estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly sales of $15.50 million which missed the analyst consensus estimate of $16.20 million by 4.32 percent. This is a 98.44 percent increase over sales of $7.81 million the
Benzinga Insights

Mon May 15, 2023

Earnings Scheduled For May 15, 2023

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.
Bill Haddad

Mon Mar 20, 2023

Sanara MedTech FY22 Revenue $45.8M, Up 90% YoY
Benzinga Insights

Mon Mar 20, 2023

Earnings Scheduled For March 20, 2023

Companies Reporting Before The Bell • Niu Technologies (NASDAQ:NIU) is likely to report earnings for its fourth quarter.
Benzinga Insights

Fri Mar 17, 2023

Earnings Outlook For Sanara MedTech
Michael Horton

Fri Feb 24, 2023

Sanara MedTech Says Co. Entered Into Sales Agreement With Cantor Fitzgerald Relating To $75M Of Common Stock Shares Offered By Prospectus
Happy Mohamed

Wed Feb 22, 2023

Sanara MedTech Inc. Announces Unaudited Preliminary Results For Q4 And FY22; Q4 Net Revenue Of $15.3M; FY22 Net Revenue Of $45.8M

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a medical technology company focused on
Michael Horton

Mon Nov 14, 2022

Sanara MedTech Q3 Sales $13.00M Miss $14.70M Estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly sales of $13.00 million which missed the analyst consensus estimate of $14.70 million by 11.56 percent. This is a 123.21 percent increase over sales of $5.82 million the
Benzinga Insights

Mon Nov 14, 2022

Earnings Scheduled For November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Charles Gross

Thu Nov 3, 2022

InfuSystem and Sanara MedTech Announced Wound Therapy Partnership

InfuSystem Holdings, Inc. (NYSE: INFU) ("InfuSystem" or the "Company") and Sanara MedTech Inc.